Emerging treatments
Icatibant
Bradykinin (B2) receptor antagonists, such as icatibant, inhibit the action of bradykinin at its receptors. Icatibant has been used to treat attacks of hereditary angioedema,[60] and bradykinin receptor antagonists may in future be useful in the treatment of acute anaphylactic reactions.
Use of this content is subject to our disclaimer